General InformationPrimrose Bio is a synthetic biology and gene therapy company based in California, founded in 2019, with 51-200 employees focused on developing precision genetic medicines.
Funding & FinancialsThe company has raised Series B funding in recent years with backing from prominent biotech and venture investors focused on therapeutic innovation.
Leadership & TeamPrimrose Bio was founded by scientists with expertise in synthetic biology and gene therapy, building a team of molecular biologists and biotech executives.
Recent ActivityThe company has advanced its pipeline of in vivo gene therapy candidates targeting genetic disorders, with ongoing clinical and preclinical program development.